340 results on '"Espinosa, Joaquin"'
Search Results
2. Inhibition of the proline metabolism rate-limiting enzyme P5CS allows proliferation of glutamine-restricted cancer cells
3. Triplication of the interferon receptor locus contributes to hallmarks of Down syndrome in a mouse model
4. Cell differentiation modifies the p53 transcriptional program through a combination of gene silencing and constitutive transactivation
5. Down syndrome is associated with altered frequency and functioning of tracheal multiciliated cells, and response to influenza virus infection
6. Interferon hyperactivity impairs cardiogenesis in Down syndrome via downregulation of canonical Wnt signaling
7. Further understanding the connection between Alzheimer's disease and Down syndrome
8. FAM193A is a positive regulator of p53 activity
9. Neuroimaging Abnormalities Predict Immunotherapy Responsiveness in Down Syndrome Regression Disorder (S37.009)
10. IGF1 deficiency integrates stunted growth and neurodegeneration in Down syndrome
11. Multi-omics investigation reveals functional specialization of transcriptional cyclin dependent kinases in cancer biology
12. PPM1D suppresses p53-dependent transactivation and cell death by inhibiting the Integrated Stress Response
13. Jak Inhibition in Down Syndrome Regression Disorder
14. Trisomy 21 dysregulates T cell lineages toward an autoimmunity-prone state associated with interferon hyperactivity
15. Precocious clonal hematopoiesis in Down syndrome is accompanied by immune dysregulation
16. Cardiopulmonary Phenotypes and Protein Signatures in Children With Down Syndrome.
17. Neuroimaging abnormalities associated with immunotherapy responsiveness in Down syndrome regression disorder.
18. Down Syndrome and COVID-19: A Perfect Storm?
19. Multi-omics analysis reveals contextual tumor suppressive and oncogenic gene modules within the acute hypoxic response
20. Multimodal analysis of dysregulated heme metabolism, hypoxic signaling, and stress erythropoiesis in Down syndrome
21. Multi-Omic Approaches Identify Metabolic and Autophagy Regulators Important in Ovarian Cancer Dissemination
22. Plasma neurofilament light chain concentrations are elevated in youth‐onset type 2 diabetes and associated with neuropathy
23. Supplementary File 3 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
24. Supplementary File 6 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
25. Data from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
26. Supplementary File 4 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
27. Supplementary File 8 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
28. Supplementary File 7 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
29. Supplementary File 1 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
30. Supplementary File 5 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
31. Supplementary File 2 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
32. EYA2 Tyrosine Phosphatase Inhibition Reduces MYC and Prevents Medulloblastoma Progression
33. Metabolic signatures of cardiorenal dysfunction in plasma from sickle cell patients as a function of therapeutic transfusion and hydroxyurea treatment
34. Mediator kinase inhibition suppresses hyperactive interferon signaling in Down syndrome
35. Addressing challenges in health care and research for people with Down syndrome
36. Adaptive changes in global gene expression profile of lung carcinoma A549 cells acutely exposed to distinct types of AhR ligands
37. Exosomal biomarkers in Down syndrome and Alzheimer's disease
38. Multidimensional definition of the interferonopathy of Down syndrome and its response to JAK inhibition
39. Cardiopulmonary Phenotypes and Protein Signatures in Children With Down Syndrome
40. Triplication of HSA21-encoded genes modulates Alzheimer’s Disease-related phenotypes in vivo
41. Metabolic signatures of cardiorenal dysfunction in plasma from sickle cell patients, as a function of therapeutic transfusion and hydroxyurea treatment
42. Abstract 1510: Clonal hematopoiesis in Down syndrome and its potential impact on hematopoietic lineages
43. Supplementary Table 1 from p53 Family Members Regulate Phenotypic Response to Aurora Kinase A Inhibition in Triple-Negative Breast Cancer
44. Supplementary Figure 1 from p53 Family Members Regulate Phenotypic Response to Aurora Kinase A Inhibition in Triple-Negative Breast Cancer
45. Supplementary Table 4 from p53 Family Members Regulate Phenotypic Response to Aurora Kinase A Inhibition in Triple-Negative Breast Cancer
46. Supplementary Figure 4 from p53 Family Members Regulate Phenotypic Response to Aurora Kinase A Inhibition in Triple-Negative Breast Cancer
47. Supplementary Figure Legends from p53 Family Members Regulate Phenotypic Response to Aurora Kinase A Inhibition in Triple-Negative Breast Cancer
48. Supplementary Figure 3 from p53 Family Members Regulate Phenotypic Response to Aurora Kinase A Inhibition in Triple-Negative Breast Cancer
49. Supplementary Table 3 from p53 Family Members Regulate Phenotypic Response to Aurora Kinase A Inhibition in Triple-Negative Breast Cancer
50. Supplementary Figure 2 from p53 Family Members Regulate Phenotypic Response to Aurora Kinase A Inhibition in Triple-Negative Breast Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.